Angel News

Back to Homepage

8th March 2024 - 0 comments

Newcells Biotech raises £2.35m for lab models that help avoid animal testing

Newcells Biotech, whose laboratory models are used in drug development and reduce reliance on animal testing, has raised a further £2.35m to boost its growth and help establish itself as a global leader in its field. 

The Newcastle-based company has secured funding from existing investors including the North East Venture Fund, supported by the European Regional Development Fund and managed by Mercia Ventures, Mercia’s own funds and Northstar Ventures. It brings the total raised by the company to date to over £12m.


Register / Login now to read full story

In order to read the full story we need you to be registered with us, please click the links below to login or register.

Login / Register

Add a comment:




Enter the characters in the image shown:

Back to Homepage